Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease

[1] Sin DD(2003)Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 1514-1519

[2] Man SF(2010)Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 1128-1138

[3] Hurst JR(2012)Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD Eur Respir J 39 1097-1103

[4] Vestbo J(1981)Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Lancet 1 681-686

[5] Anzueto A(1980)Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial Ann Intern Med 93 391-398

[6] McAllister DA(2007)The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris Am J Hypertens 20 1029-1035

[7] Maclay JD(2005)Left ventricular hypertrophy as a predictor of cardiovascular risk J Hypertens Suppl 23 S27-S33

[8] Mills NL(1995)The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults JAMA 273 1592-1597

[9] Ang DS(1995)Left atrial size and the risk of stroke and death. The Framingham Heart Study Circulation 92 835-841

[10] Pringle SD(1995)Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease Am J Med 98 272-277

[1] Sin DD(2003)Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 1514-1519

[2] Man SF(2010)Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 1128-1138

[3] Hurst JR(2012)Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD Eur Respir J 39 1097-1103

[4] Vestbo J(1981)Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Lancet 1 681-686

[5] Anzueto A(1980)Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial Ann Intern Med 93 391-398

[6] McAllister DA(2007)The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris Am J Hypertens 20 1029-1035

[7] Maclay JD(2005)Left ventricular hypertrophy as a predictor of cardiovascular risk J Hypertens Suppl 23 S27-S33

[8] Mills NL(1995)The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults JAMA 273 1592-1597

[9] Ang DS(1995)Left atrial size and the risk of stroke and death. The Framingham Heart Study Circulation 92 835-841

[10] Pringle SD(1995)Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease Am J Med 98 272-277